摘要
目的:分析黄体酮治疗黄体功能不全所致先兆流产的临床疗效。方法:选取2016年5月—2017年5月我院收治的因黄体功能不全所致先兆流产100例患者为研究对象,按随机数字表法分为两组,各50例。两组均接受常规治疗,对照组给予绒毛膜促性腺激素(2 000 U,qod)治疗,观察组给予黄体酮注射液(20 mg,qd)治疗,2周后,比较两组疗效及不良反应发生情况。结果 :观察组治疗有效率明显高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率差异无统计学意义(P>0.05)。结论 :黄体酮治疗黄体功能不全所致先兆流产的疗效显著,安全性高,值得临床推广使用。
Objective: To analyze the clinical efficacy of progesterone in the treatment of threatened abortion caused by luteal insufficiency. Methods: 100 cases of patients with threatened abortion caused by luteal insufficiency admitted to our hospital from May 2016 to May 2017 were selected as subjects and divided into two groups according to the random number table method, 50 cases in each group. The patients in the two groups received routine treatment. The patients in the control group were given chorionic gonadotropin(2 000 U, qod), and the patients in the observation group were given progesterone injection(20 mg, qd). After 2 weeks of the treatment, the clinical efficacy and the occurrence of adverse reactions were compared between the two groups. Results: The effective rate of the observation group was significantly higher than that of the control group, and the difference was statistically significant(P<0.05); there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05). Conclusion: Progesterone has significant clinical efficacy and high safety in the treatment of threatened abortion caused by luteal insufficiency, and is worthy of clinical use.
出处
《中国执业药师》
CAS
2018年第8期15-16,20,共3页
China Licensed Pharmacist
关键词
黄体酮
黄体功能不全
先兆流产
安全性
Progesterone
Luteal Insufficiency
Threatened Abortion
Safety